Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

The 2019 coronavirus disease (COVID-19), caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed serious threats to global public health and economic and social stabilities, calling for the prompt development of therapeutics and prophylactics. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanmei, Yu, Danwei, Yan, Hongxia, Chong, Huihui, He, Yuxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343218/
https://www.ncbi.nlm.nih.gov/pubmed/32376627
http://dx.doi.org/10.1128/JVI.00635-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343218/
https://www.ncbi.nlm.nih.gov/pubmed/32376627
http://dx.doi.org/10.1128/JVI.00635-20

Ejemplares similares